Sage Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Buy
87,958
+975
+1% +$56K 1.05% 35
2026
Q1
$5.28M Buy
86,983
+305
+0.4% +$17.8K 1.22% 30
2025
Q4
$4.68M Sell
86,678
-513
-0.6% -$24.7K 1.11% 30
2025
Q3
$3.93M Buy
87,191
+1,957
+2% +$91.4K 0.94% 37
2025
Q2
$3.95M Buy
85,234
+32,181
+61% +$1.58M 0.97% 36
2025
Q1
$3.24M Sell
53,053
-3,986
-7% -$232K 0.85% 40
2024
Q4
$3.23M Buy
57,039
+567
+1% +$31.7K 0.84% 40
2024
Q3
$2.92M Buy
56,472
+1,065
+2% +$50K 0.76% 42
2024
Q2
$2.3M Sell
55,407
-2,406
-4% -$108K 0.66% 43
2024
Q1
$3.14M Buy
57,813
+1,408
+2% +$71.7K 0.91% 42
2023
Q4
$2.89M Sell
56,405
-12,265
-18% -$644K 0.94% 38
2023
Q3
$3.99M Buy
68,670
+1,384
+2% +$84.8K 1.46% 23
2023
Q2
$4.3M Buy
67,286
+8,377
+14% +$562K 1.51% 22
2023
Q1
$4.08M Buy
58,909
+769
+1% +$54.2K 1.56% 22
2022
Q4
$4.18M Buy
58,140
+7,112
+14% +$536K 1.85% 20
2022
Q3
$3.63M Sell
51,028
-1,694
-3% -$123K 1.85% 18
2022
Q2
$4.06M Sell
52,722
-60,243
-53% -$4.59M 1.94% 17
2022
Q1
$8.79M Buy
112,965
+834
+0.7% +$56K 3.57% 4
2021
Q4
$7.26M Buy
112,131
+22,999
+26% +$1.35M 2.75% 5
2021
Q3
$5.27M Buy
89,132
+826
+0.9% +$54.4K 2.24% 8
2021
Q2
$5.93M Buy
88,306
+5,500
+7% +$359K 2.42% 7
2021
Q1
$5.23M Buy
82,806
+3,398
+4% +$211K 2.34% 6
2020
Q4
$4.89M Buy
79,408
+115
+0.1% +$7.07K 2.41% 5
2020
Q3
$4.78M Buy
79,293
+1,208
+2% +$72.7K 2.92% 4
2020
Q2
$4.59M Buy
78,085
+3,128
+4% +$187K 2.95% 5
2020
Q1
$4.18M Buy
74,957
+11,660
+18% +$713K 3.42% 4
2019
Q4
$4.06M Buy
63,297
+471
+0.7% +$27K 2.58% 5
2019
Q3
$3.19M Sell
62,826
-1,248
-2% -$58.7K 2.41% 10
2019
Q2
$2.82M Sell
64,074
-934
-1% -$43.5K 1.95% 18
2019
Q1
$3.1M Buy
65,008
+328
+0.5% +$16.3K 2% 19
2018
Q4
$3.36M Buy
64,680
+141
+0.2% +$7.58K 2.54% 11
2018
Q3
$4.01M Buy
64,539
+519
+0.8% +$30.8K 2.5% 11
2018
Q2
$3.54M Buy
+64,020
New +$3.46M 2.48% 14

Other funds holding BMY